| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_VPR_TO_WEE1_CELL_CYCLE_G2M | 1.38e-04 | 5 | 53 | 2 | M49022 | |
| Pathway | REACTOME_G2_M_DNA_REPLICATION_CHECKPOINT | 1.38e-04 | 5 | 53 | 2 | M27669 | |
| Pathway | REACTOME_G2_M_DNA_REPLICATION_CHECKPOINT | 1.38e-04 | 5 | 53 | 2 | MM15382 | |
| Pubmed | The clinical significance of Cyclin B1 and Wee1 expression in non-small-cell lung cancer. | 4.35e-06 | 2 | 73 | 2 | 14760118 | |
| Pubmed | Characterization of Spi-B, a transcription factor related to the putative oncoprotein Spi-1/PU.1. | 4.35e-06 | 2 | 73 | 2 | 1406622 | |
| Pubmed | PU.1 and Spi-B are required for normal B cell receptor-mediated signal transduction. | 4.35e-06 | 2 | 73 | 2 | 10229183 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 16301746 | ||
| Pubmed | Environmental sensing by mature B cells is controlled by the transcription factors PU.1 and SpiB. | 4.35e-06 | 2 | 73 | 2 | 29127283 | |
| Pubmed | Genome-wide comparison of PU.1 and Spi-B binding sites in a mouse B lymphoma cell line. | 4.35e-06 | 2 | 73 | 2 | 25765478 | |
| Pubmed | Analysis of gene expression and Ig transcription in PU.1/Spi-B-deficient progenitor B cell lines. | 4.35e-06 | 2 | 73 | 2 | 14688320 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 10840049 | ||
| Pubmed | PU.1/Spi-B regulation of c-rel is essential for mature B cell survival. | 4.35e-06 | 2 | 73 | 2 | 11672537 | |
| Pubmed | 6.95e-06 | 58 | 73 | 4 | 11140838 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 21057087 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 28062693 | ||
| Pubmed | Assembling a gene regulatory network for specification of the B cell fate. | 1.30e-05 | 3 | 73 | 2 | 15469848 | |
| Pubmed | Genomic structure of mouse SPI-C and genomic structure and expression pattern of human SPI-C. | 1.30e-05 | 3 | 73 | 2 | 12459275 | |
| Pubmed | Inactivation of the p34cdc2-cyclin B complex by the human WEE1 tyrosine kinase. | 1.30e-05 | 3 | 73 | 2 | 1384126 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 21768304 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 25733685 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 32165090 | ||
| Pubmed | 1.74e-05 | 24 | 73 | 3 | 19706712 | ||
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 28387756 | ||
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 20372791 | ||
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 30598363 | ||
| Pubmed | Cytotoxicity of crystals involves RIPK3-MLKL-mediated necroptosis. | 2.60e-05 | 4 | 73 | 2 | 26817517 | |
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 11864910 | ||
| Pubmed | New gene in the homologous human 11q13-q14 and mouse 7F chromosomal regions. | 2.60e-05 | 4 | 73 | 2 | 1543912 | |
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 22956576 | ||
| Pubmed | Spi-B can functionally replace PU.1 in myeloid but not lymphoid development. | 2.60e-05 | 4 | 73 | 2 | 11980719 | |
| Pubmed | Transient suppression of nuclear Cdc2 activity in response to ionizing radiation. | 2.60e-05 | 4 | 73 | 2 | 18425394 | |
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 38874119 | ||
| Pubmed | Control mechanism of the circadian clock for timing of cell division in vivo. | 4.33e-05 | 5 | 73 | 2 | 12934012 | |
| Pubmed | 4.33e-05 | 5 | 73 | 2 | 19382941 | ||
| Pubmed | 4.33e-05 | 5 | 73 | 2 | 16263717 | ||
| Pubmed | 4.33e-05 | 5 | 73 | 2 | 25505273 | ||
| Pubmed | Differential phosphorylations of Spi-B and Spi-1 transcription factors. | 4.33e-05 | 5 | 73 | 2 | 8632909 | |
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | 5.85e-05 | 639 | 73 | 8 | 23443559 | |
| Pubmed | Integration of innate immune signalling by caspase-8 cleavage of N4BP1. | 6.48e-05 | 6 | 73 | 2 | 32971525 | |
| Pubmed | Human prostate epithelium lacks Wee1A-mediated DNA damage-induced checkpoint enforcement. | 6.48e-05 | 6 | 73 | 2 | 17431037 | |
| Pubmed | 6.48e-05 | 6 | 73 | 2 | 10364157 | ||
| Pubmed | OTULIN inhibits RIPK1-mediated keratinocyte necroptosis to prevent skin inflammation in mice. | 9.06e-05 | 7 | 73 | 2 | 34625557 | |
| Pubmed | 9.06e-05 | 7 | 73 | 2 | 27756058 | ||
| Pubmed | 9.06e-05 | 7 | 73 | 2 | 38788712 | ||
| Pubmed | Dynamic disruptions in nuclear envelope architecture and integrity induced by HIV-1 Vpr. | 9.06e-05 | 7 | 73 | 2 | 11691994 | |
| Pubmed | RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis. | 9.06e-05 | 7 | 73 | 2 | 24813849 | |
| Pubmed | 9.06e-05 | 7 | 73 | 2 | 10196196 | ||
| Pubmed | 9.06e-05 | 7 | 73 | 2 | 27411587 | ||
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 1.09e-04 | 358 | 73 | 6 | 32460013 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | 1.20e-04 | 910 | 73 | 9 | 36736316 | |
| Pubmed | RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis. | 1.21e-04 | 8 | 73 | 2 | 25132550 | |
| Pubmed | 1.21e-04 | 8 | 73 | 2 | 9499405 | ||
| Pubmed | 1.21e-04 | 8 | 73 | 2 | 19858290 | ||
| Pubmed | Cdc25 phosphatases are required for timely assembly of CDK1-cyclin B at the G2/M transition. | 1.21e-04 | 8 | 73 | 2 | 20360007 | |
| Pubmed | 1.21e-04 | 8 | 73 | 2 | 32075762 | ||
| Pubmed | The role of Cdc2 feedback loop control in the DNA damage checkpoint in mammalian cells. | 1.21e-04 | 8 | 73 | 2 | 9371520 | |
| Pubmed | Tissue-specific requirements for FGF8 during early inner ear development. | 1.55e-04 | 9 | 73 | 2 | 19619645 | |
| Pubmed | 1.55e-04 | 9 | 73 | 2 | 27560715 | ||
| Pubmed | Dendritic Cell RIPK1 Maintains Immune Homeostasis by Preventing Inflammation and Autoimmunity. | 1.55e-04 | 9 | 73 | 2 | 29212904 | |
| Pubmed | 1.93e-04 | 53 | 73 | 3 | 36841324 | ||
| Pubmed | TAK1 restricts spontaneous NLRP3 activation and cell death to control myeloid proliferation. | 1.93e-04 | 10 | 73 | 2 | 29500178 | |
| Pubmed | OTULIN maintains skin homeostasis by controlling keratinocyte death and stem cell identity. | 1.93e-04 | 10 | 73 | 2 | 34625556 | |
| Pubmed | Interactions of HIV-1 viral protein R with host cell proteins. | 1.93e-04 | 10 | 73 | 2 | 17586317 | |
| Pubmed | Ubiquitin Ligases cIAP1 and cIAP2 Limit Cell Death to Prevent Inflammation. | 1.93e-04 | 10 | 73 | 2 | 31141691 | |
| Pubmed | 1.93e-04 | 10 | 73 | 2 | 18514189 | ||
| Pubmed | Mapping the interactome of HPV E6 and E7 oncoproteins with the ubiquitin-proteasome system. | 2.09e-04 | 138 | 73 | 4 | 28786561 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 2.22e-04 | 582 | 73 | 7 | 20467437 | |
| Pubmed | LUBAC is essential for embryogenesis by preventing cell death and enabling haematopoiesis. | 2.36e-04 | 11 | 73 | 2 | 29695863 | |
| Pubmed | 2.36e-04 | 11 | 73 | 2 | 31073027 | ||
| Pubmed | ZBP1 and TRIF trigger lethal necroptosis in mice lacking caspase-8 and TNFR1. | 2.36e-04 | 11 | 73 | 2 | 38548850 | |
| Pubmed | 2.36e-04 | 11 | 73 | 2 | 25189618 | ||
| Pubmed | 2.36e-04 | 11 | 73 | 2 | 22649246 | ||
| Pubmed | Cleavage of RIPK1 by caspase-8 is crucial for limiting apoptosis and necroptosis. | 2.36e-04 | 11 | 73 | 2 | 31511692 | |
| Pubmed | Planar cell polarity defects and defective Vangl2 trafficking in mutants for the COPII gene Sec24b. | 2.83e-04 | 12 | 73 | 2 | 20215345 | |
| Pubmed | SHLD2/FAM35A co-operates with REV7 to coordinate DNA double-strand break repair pathway choice. | 2.87e-04 | 150 | 73 | 4 | 30154076 | |
| Pubmed | 3.34e-04 | 13 | 73 | 2 | 22443383 | ||
| Pubmed | TNF-α Coordinates Hematopoietic Stem Cell Survival and Myeloid Regeneration. | 3.34e-04 | 13 | 73 | 2 | 31230859 | |
| Pubmed | 3.89e-04 | 14 | 73 | 2 | 15265780 | ||
| Pubmed | 3.89e-04 | 14 | 73 | 2 | 37085671 | ||
| Pubmed | 3.89e-04 | 14 | 73 | 2 | 31519886 | ||
| Pubmed | Function of PEA3 Ets transcription factors in mammary gland development and oncogenesis. | 3.89e-04 | 14 | 73 | 2 | 14635793 | |
| Pubmed | Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis. | 4.48e-04 | 15 | 73 | 2 | 24557836 | |
| Pubmed | 4.48e-04 | 15 | 73 | 2 | 29203883 | ||
| Pubmed | 4.56e-04 | 304 | 73 | 5 | 32235678 | ||
| Pubmed | 5.12e-04 | 16 | 73 | 2 | 24145799 | ||
| Pubmed | RIPK1 prevents TRADD-driven, but TNFR1 independent, apoptosis during development. | 5.12e-04 | 16 | 73 | 2 | 30185824 | |
| Pubmed | 5.12e-04 | 16 | 73 | 2 | 24744753 | ||
| Pubmed | Structure-function relationship of Vpr: biological implications. | 5.12e-04 | 16 | 73 | 2 | 19275588 | |
| Pubmed | Congenital Muscular Dystrophy Overview – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY | 5.79e-04 | 17 | 73 | 2 | 20301468 | |
| Pubmed | Otx2 is a target of N-myc and acts as a suppressor of sensory development in the mammalian cochlea. | 5.79e-04 | 17 | 73 | 2 | 26160903 | |
| Pubmed | The G protein-coupled receptor repertoires of human and mouse. | 6.26e-04 | 79 | 73 | 3 | 12679517 | |
| Pubmed | A unique death pathway keeps RIPK1 D325A mutant mice in check at embryonic day 10.5. | 6.51e-04 | 18 | 73 | 2 | 34437534 | |
| Pubmed | Modulating TRADD to restore cellular homeostasis and inhibit apoptosis. | 6.51e-04 | 18 | 73 | 2 | 32968279 | |
| Pubmed | Meis2 Is Required for Inner Ear Formation and Proper Morphogenesis of the Cochlea. | 7.26e-04 | 19 | 73 | 2 | 34124068 | |
| Pubmed | 8.01e-04 | 197 | 73 | 4 | 32434143 | ||
| Pubmed | 8.06e-04 | 20 | 73 | 2 | 26511239 | ||
| Pubmed | Essential roles of G9a in cell proliferation and differentiation during tooth development. | 8.06e-04 | 20 | 73 | 2 | 28527696 | |
| Pubmed | Human immunodeficiency virus type 1 Vpr: functions and molecular interactions. | 8.06e-04 | 20 | 73 | 2 | 19458171 | |
| Pubmed | Fibroblastic reticular cell lineage convergence in Peyer's patches governs intestinal immunity. | 8.06e-04 | 20 | 73 | 2 | 33707780 | |
| Pubmed | Hierarchical organization of cortical and thalamic connectivity. | 1.16e-03 | 24 | 73 | 2 | 31666704 | |
| Pubmed | 1.16e-03 | 24 | 73 | 2 | 9606417 | ||
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | 1.24e-03 | 1257 | 73 | 9 | 37317656 | |
| Pubmed | 1.26e-03 | 25 | 73 | 2 | 35139355 | ||
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.79e-08 | 199 | 73 | 7 | 9735a1dc10910f02f1106b20ae5ab4c09c21305e | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuroepithelial|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 3.92e-08 | 200 | 73 | 7 | 8b80811a0ec28d1d763c10b095d1969bccbe82d4 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuroepithelial-Proteoglycan-expressing_cell|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 3.92e-08 | 200 | 73 | 7 | 52ec80f3922ae6ee3565d5993c2fc56bb3a3199a | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.43e-07 | 187 | 73 | 6 | dffa8447c2f3fdacf39a7258c6b4e81a25245041 | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-Early_cap|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.50e-07 | 192 | 73 | 6 | 4986ef70a665fdfa1df86f7f8a15117487eae159 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.45e-07 | 196 | 73 | 6 | ae46d4b00be92e64e46252dcc156161b171eded4 | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.51e-07 | 200 | 73 | 6 | 5ec31c1be6bcc4124e1489d136570f3de33cc2e9 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Mesenchymal|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 9.51e-07 | 200 | 73 | 6 | 5c638c80661017c85f9390f1b398ac7728c8f001 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Mesenchymal-BMP_responsible_cell|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 9.51e-07 | 200 | 73 | 6 | 604a88633d4162337e394155c7346dbdef8b9f5a | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 9.51e-07 | 200 | 73 | 6 | 3585484c7e24e941708bee471ca607d8ccee74e6 | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Pheochromocytoma-Pheochromocytoma-3|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 6.80e-06 | 161 | 73 | 5 | 52239a887799362256ecd7e740b716b88ed59a62 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-B_(Artery)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 9.64e-06 | 173 | 73 | 5 | ec88e871b49331fca59bc610a8ae58e2d5e76bc1 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-B_(Artery)|368C / Donor, Lineage, Cell class and subclass (all cells) | 9.64e-06 | 173 | 73 | 5 | 22200fe74e33e2beae0eed289ca8476bbc0b1b2d | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-lung_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.02e-05 | 175 | 73 | 5 | f5822cf48777880e670a6a18158ffb31d066c24a | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.02e-05 | 175 | 73 | 5 | cddbd42c1cdfcdf2a41d96198ddb20e684ee6317 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular-Interstitial_macrophage_perivascular_L.1.2.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.02e-05 | 175 | 73 | 5 | 067f77c5d9ae3cf960b84ece80c25d5193873cbf | |
| ToppCell | NS-critical-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.05e-05 | 176 | 73 | 5 | 7cf1a06ceee1ec06532f44c729c31b4d58e5ea49 | |
| ToppCell | 3'-Adult-Distal_Rectal-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.11e-05 | 178 | 73 | 5 | c30d3390fc4a7856f50ba8ff6694c0333165ddde | |
| ToppCell | facs-Pancreas-Endocrine-24m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-05 | 179 | 73 | 5 | 6f51a4580c06fc55cc764052c9b26f7c55660282 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-05 | 179 | 73 | 5 | f14440f6ce9b4fcdd4bcb2488b949f9a0e17bc23 | |
| ToppCell | Endothelial-A-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 1.14e-05 | 179 | 73 | 5 | 138fd6ba6bdbd0ad01c574168addf720b67a0fea | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.14e-05 | 179 | 73 | 5 | 1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba | |
| ToppCell | facs-Pancreas-Endocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-05 | 179 | 73 | 5 | a6ce1fa338d4905bd6afef00763ac83e916a0b37 | |
| ToppCell | COVID-19-Heart-EC_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.14e-05 | 179 | 73 | 5 | 2a53d94f6c30bf887dfe88f1693ea057218c852d | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.17e-05 | 180 | 73 | 5 | 455d1e3ccf2ab609954f3b870e8f514ddca735f4 | |
| ToppCell | Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.23e-05 | 182 | 73 | 5 | da61e7cb2537c567968d8bd8baf537ecdff0ab18 | |
| ToppCell | Cerebellum-Endothelial-MURAL|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.23e-05 | 182 | 73 | 5 | b2f03f61aebb5920595fed8b9d6799a09353419b | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.33e-05 | 185 | 73 | 5 | 808d5e880069aff8866cd2c733b9fe568a37701f | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.37e-05 | 186 | 73 | 5 | 7c1807fca590cdccf7f5734460bac228d33964ca | |
| ToppCell | Endothelial-A-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 1.40e-05 | 187 | 73 | 5 | fd93f3f4b82dae3bf4eef245bfedc2a9e3251b61 | |
| ToppCell | wk_08-11-Endothelial-Blood_vessel_endothelial-GRIA2+_arterial_endo|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.40e-05 | 187 | 73 | 5 | a27aa97aa6508a3ffe92c2b6bb0511a95650a390 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_immature-endo_immature_arterial2_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.44e-05 | 188 | 73 | 5 | b66f1f08827dd6c48583d871f9f33ea41e48bfb2 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.48e-05 | 189 | 73 | 5 | db09d591b885ce2bc9e353f08b6694e2192582e1 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Myeloid-Macrophages|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.48e-05 | 189 | 73 | 5 | b8cbfc47f3f40b6fccd15899d58c87d07b0001aa | |
| ToppCell | Macrophages-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.48e-05 | 189 | 73 | 5 | c05b4b565c0ce56dbb45fc9503654a2ec1a7e1e9 | |
| ToppCell | Endothelial-A-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 1.52e-05 | 190 | 73 | 5 | 6e83fa0eb8cabe0ffb35375f16e6bf3755ec4977 | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_mature-endo_arterial_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.52e-05 | 190 | 73 | 5 | 1307688255a1250fa300edf2c41f1affe31dcc98 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.52e-05 | 190 | 73 | 5 | 06bfb62b94b0faf467ef93d5bc5d08924c770098 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-05 | 191 | 73 | 5 | b9ae5af426e7a1f2652a47700bb168371bd2dec6 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.59e-05 | 192 | 73 | 5 | 0e7e55505bd5454d7cf952a63fdcb46ec76f1973 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.59e-05 | 192 | 73 | 5 | 32acd89617934016cd135d2cc797e8e79ae1b37f | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-05 | 193 | 73 | 5 | 858a186804b36d45957238d3d3eed2768b961641 | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.63e-05 | 193 | 73 | 5 | 1e6e2d786511cc40241197368f5df20c20b882f3 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-05 | 193 | 73 | 5 | 7865e7ec0a288249540d4cba94ae01c93e1b617c | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.63e-05 | 193 | 73 | 5 | 025836c5c5a711e477c326559e618e47cae42d11 | |
| ToppCell | IPF-Endothelial-VE_Arterial|World / Disease state, Lineage and Cell class | 1.63e-05 | 193 | 73 | 5 | 70a9aadda83a97e06e9bc2d1327ce60dd3c58767 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.68e-05 | 194 | 73 | 5 | b8aa48d7774e4da3351ee2177eb694fcfec7cbc3 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.72e-05 | 195 | 73 | 5 | 56efeb58df19f357d7d5ce87348d4f196a595421 | |
| ToppCell | Control-Endothelial-VE_Arterial|Control / Disease state, Lineage and Cell class | 1.72e-05 | 195 | 73 | 5 | 56c66a3655820961e1390b8f4bcc5618e8d0c5a8 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_anti-infl|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.72e-05 | 195 | 73 | 5 | 0ec1b572bbb92b6da3440139366a4c1743b1ad92 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-05 | 196 | 73 | 5 | 2aa1acea3cefb3dbe3afdb04875c96b927e9d860 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-05 | 196 | 73 | 5 | 59ca204c96149fdff08bc524cfa832a30e60e8a4 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Mesenchymal|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-05 | 196 | 73 | 5 | d06a29775a41223e02728615af519a18f7e82e8b | |
| ToppCell | COVID-19-lung-Macrophage_metabolically_active|lung / Disease (COVID-19 only), tissue and cell type | 1.76e-05 | 196 | 73 | 5 | a753d76d764c181eecb0e17a794a2e7d0ff70136 | |
| ToppCell | wk_08-11-Endothelial-Blood_vessel_endothelial-Early_cap|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.76e-05 | 196 | 73 | 5 | 0f00aac6dac699507ce336020b2e96fd192de0be | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.76e-05 | 196 | 73 | 5 | ed818de15f84f7f28bd06fd69d7876710da232a0 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.80e-05 | 197 | 73 | 5 | 62c0a90869431e582bb7bb329e0b0cc59123d3d1 | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.80e-05 | 197 | 73 | 5 | ad4a3b5da2190be9495382a2952991e1de9f190d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.80e-05 | 197 | 73 | 5 | 983502a99e6d59bb36225b0246a9990604de1a01 | |
| ToppCell | Enterocyte|World / shred on cell type and cluster | 1.80e-05 | 197 | 73 | 5 | 1dd980fd066aef21694395a4b69df938501d9631 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.80e-05 | 197 | 73 | 5 | 16f0eb047df9d702518f82ee99c6e7dc1350b2fb | |
| ToppCell | C_01|World / shred on cell type and cluster | 1.85e-05 | 198 | 73 | 5 | 71d38084d09a96331877384ce6346f0de4bdcef9 | |
| ToppCell | 5'-Adult-Distal_Rectal-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.85e-05 | 198 | 73 | 5 | 8a55589b9244283e4b0b423a4a6d6202e8e0fec9 | |
| ToppCell | 5'-Adult-Distal_Rectal-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.85e-05 | 198 | 73 | 5 | d1f54ed3ef5e05ebda7da999e172d168dc6802cd | |
| ToppCell | 5'-Adult-Distal_Rectal-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.85e-05 | 198 | 73 | 5 | 8d6b0b9da7c1e64155cbcbb04ad38d129a29030c | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.85e-05 | 198 | 73 | 5 | b11d21aa96a0c91e958ae7ed8fd56546aeaebb91 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Endothelial-Endothelial|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.85e-05 | 198 | 73 | 5 | 531b0f88c95f813e3914c96749f591e80ca321d0 | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.85e-05 | 198 | 73 | 5 | 58508a8df2714d769f137794c29441a7bd38b350 | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.85e-05 | 198 | 73 | 5 | 605ef5b61750226b93bca48166d8a1f6450e80e0 | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Myeloid-Granulocytic_cells-Mast-cells|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.89e-05 | 199 | 73 | 5 | 892ca0dc9928d3985bf99de8afc68c06d22e6e2e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.89e-05 | 199 | 73 | 5 | d95d78b2ebc9a20532466e4d4be579b4faf6776f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.89e-05 | 199 | 73 | 5 | cdcfca94baba66e213cc3ffb0cfb4c75d6ab44ec | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.89e-05 | 199 | 73 | 5 | 9545ac59c8d75f5747dff86cb511a149dc103b31 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.89e-05 | 199 | 73 | 5 | 236b1417ed0875e98c6ec1ec714003bfce438d65 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.89e-05 | 199 | 73 | 5 | 0602e2b2aa56d106da63bd342a38bef437b4d496 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.89e-05 | 199 | 73 | 5 | 463ba77dc4c85eebb343f29a42c7ac889b0497c9 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.89e-05 | 199 | 73 | 5 | 63c01e8961f48ed1bed4ab619cacf318cd6de7b9 | |
| ToppCell | wk_20-22-Endothelial-Blood_vessel_endothelial|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.89e-05 | 199 | 73 | 5 | 243b7c72f83c12a34d8ea300fca63b04216268a4 | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.94e-05 | 200 | 73 | 5 | ac6b8bc9998d303f788511b8f111e682ea9f3df8 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 1.94e-05 | 200 | 73 | 5 | 6f531a418ff25b59a543800cf4bce7b72404ce08 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.94e-05 | 200 | 73 | 5 | 86ec951234015ced7126b016199e5869a0f22478 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.94e-05 | 200 | 73 | 5 | 7547d6339f9380d031cfd2cce21ac9a12491e085 | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.94e-05 | 200 | 73 | 5 | cd3c638961144a2fc91c437a173cc37c7452fa74 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.94e-05 | 200 | 73 | 5 | 78d75d381cb2b9a4c9eb7c32a07b014eaee39195 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.94e-05 | 200 | 73 | 5 | c239e6f5d23caa9a59b83e9b352b2d6a691dcb28 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.94e-05 | 200 | 73 | 5 | 061ba851f941c616ddb462512e826c412881c3ce | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Adora2a|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.12e-05 | 109 | 73 | 4 | e8e0f2c5f8c9e45f2b4d173569c94275eedfe432 | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_STALK|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.05e-04 | 149 | 73 | 4 | d9c47f523c75ddcd6131e45d2ffc24b970932cae | |
| ToppCell | facs-Trachea-nan-24m|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 154 | 73 | 4 | 206fc37c165d5b8e4339578d49d7743b50dde6aa | |
| ToppCell | facs-Trachea-24m|Trachea / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.20e-04 | 154 | 73 | 4 | 75897e35b0e22811a30f8e63ebe65b43aa714f0d | |
| ToppCell | PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor1_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.39e-04 | 160 | 73 | 4 | 7f1b58641ba149d20420fafad34ba78a65a2c701 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Granulocytic-Mast_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-04 | 160 | 73 | 4 | fe9970c160159b35f6599ed13c89cfb49264d554 | |
| ToppCell | E18.5-samps-Myeloid-Macrophage-macrophage_-_intermediate_-_unactivated|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.45e-04 | 162 | 73 | 4 | 60d3fe1f5cec4285b8774ff078ebcc6bfaec26ed | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_artery-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.45e-04 | 162 | 73 | 4 | 25bb1b9709f960fdf90faff56e874f52a8f5d17e | |
| ToppCell | E18.5-samps-Myeloid|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.45e-04 | 162 | 73 | 4 | 18e4a807e25f754a69e9eaaddfde40f8de9b8512 | |
| ToppCell | E18.5-samps-Myeloid-Macrophage|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.45e-04 | 162 | 73 | 4 | 0970e4eda60e3f015335e2726e6d565fb2f43372 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.45e-04 | 162 | 73 | 4 | 56f1789e69a6cb29956e46aba92b290847327c1f | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.52e-04 | 164 | 73 | 4 | 3cd80e6275f0f9b5667912139d15ebf5e6b17f2f | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.52e-04 | 164 | 73 | 4 | e24b06a14565f7798ac50c2fe3f34d4547b9000e | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-Tuft-related-Tuft|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.56e-04 | 165 | 73 | 4 | 34fd00be2b28716c871ad9fb356de84a299a0c01 | |
| Disease | alcohol use disorder (biomarker_via_orthology) | 4.96e-04 | 14 | 70 | 2 | DOID:1574 (biomarker_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 5.71e-04 | 15 | 70 | 2 | DOID:0050646 (implicated_via_orthology) | |
| Disease | Herpes Zoster | 7.37e-04 | 17 | 70 | 2 | EFO_0006510 | |
| Disease | Anorexia | 8.28e-04 | 18 | 70 | 2 | C0003123 | |
| Disease | Infiltrating duct carcinoma of female breast | 1.13e-03 | 21 | 70 | 2 | C3165106 | |
| Disease | Etat Marbre | 1.36e-03 | 23 | 70 | 2 | C0266487 | |
| Disease | Weight decreased | 1.36e-03 | 23 | 70 | 2 | C1262477 | |
| Disease | Fever | 1.87e-03 | 27 | 70 | 2 | C0015967 | |
| Disease | Movement Disorders | 2.16e-03 | 29 | 70 | 2 | C0026650 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GDLFGRRTLYLDMLQ | 276 | Q8NFR7 | |
| LLMLGVYLRIFLAAR | 191 | P29274 | |
| GVMFYLLLKRSGREI | 156 | Q9Y4W6 | |
| MTLEGLYLARGPLAR | 1 | Q75N90 | |
| RRLENIRFLKGMGYS | 431 | Q9Y5A7 | |
| LHLVLSMGLQLYGFR | 226 | O60683 | |
| MLRLLRLALAFYGRT | 1 | Q8WUE5 | |
| LRGGREYNMDLYVLR | 1166 | Q96QZ7 | |
| LAVIGGLVYLRRSNM | 196 | Q9H0U3 | |
| LFSGRYLAMNKRGRL | 91 | P11487 | |
| LQLRPGALYSGLMRL | 46 | Q96SQ9 | |
| MRLEYQRLLGGRDAL | 846 | A7E2Y1 | |
| FSILGMLVGLRYLEV | 116 | Q9UKR5 | |
| LRLLYGMALVRFVNL | 111 | Q9Y4W2 | |
| IIAGMILDSRGYLFL | 406 | Q9H3U5 | |
| LRLVDNGTLLYTMRL | 171 | P34903 | |
| AMRRYLLLGQGDFIR | 561 | Q96CW5 | |
| MVYSRRGSLGSRLLL | 1 | Q9Y5H7 | |
| ALFLLGRDGYMIRRS | 141 | Q9BSG0 | |
| LRMGEEYFLRLGNLN | 66 | P06850 | |
| RMVLVLGAARGLYRL | 306 | Q8NB16 | |
| GLLRMLSVKFYSRQG | 301 | A2RRP1 | |
| LMLLSYRGILRAVRG | 196 | P46093 | |
| YLEMRLKSSFLRGLG | 16 | Q6MZN7 | |
| YLRMDALALLGGLVN | 206 | Q8N4S7 | |
| MGSAALYLLRLALRS | 31 | Q9NRX3 | |
| MGGLETSLRRLYLQG | 556 | Q14392 | |
| YLLGREVTGNMRAIL | 191 | P14635 | |
| RILYFMTRKGLINTG | 351 | Q8NB78 | |
| LNKYGDMRRLIGFSI | 1056 | Q92608 | |
| VRLFMFQLLRGLAYI | 201 | Q96Q40 | |
| MYRYLGEALLLSRAG | 1 | P00367 | |
| LRLGGIAYFLSRLMD | 646 | Q9H2U1 | |
| ALRERYLRSLLAMVG | 61 | Q9H840 | |
| LLRYRQLLGMVRGHL | 321 | Q8TDV2 | |
| FGRGFMYDRPLRLNL | 1996 | P12111 | |
| RGGILIELAMRGRIY | 76 | Q9H4A5 | |
| RRRSYLFLGGILMSA | 136 | P55061 | |
| LNLGLSFAELRRMYL | 166 | Q8NDX9 | |
| RRMYLFLNSSGLLVL | 176 | Q8NDX9 | |
| GVLRALYQLGMRYLT | 151 | P16444 | |
| LAVLGITGYFLMNRR | 301 | P28906 | |
| YLLGDMEGRLFMLLL | 271 | Q16531 | |
| LIMYLGGVFFINRQR | 131 | O15120 | |
| NLLLGTRSNLYLMDR | 1221 | Q7Z2Y5 | |
| DLRMRLLRPALGGTY | 251 | Q96CW9 | |
| LALRLMVALAYGLVG | 36 | Q8TDU9 | |
| FLMGILEAVRLYLGT | 136 | Q96HE8 | |
| ERRLSYRALQGALMI | 281 | P48775 | |
| MISGLYLGELVRLIL | 296 | Q2TB90 | |
| MAQIGLRLVLGYILL | 1576 | Q6ZNJ1 | |
| LLLMDGVRRYLCGLG | 916 | P58107 | |
| YGLMGRKNLLIFNLS | 601 | Q92854 | |
| RLYQFLLDLLRSGDM | 171 | P17947 | |
| LYQFLLGLLTRGDMR | 171 | Q01892 | |
| MFVRTRTGYLEQGLL | 211 | P29973 | |
| LGGRTYRTLLQLTRM | 161 | Q9H4F1 | |
| LLLQVGRGLRYIHSM | 406 | P30291 | |
| AFGLGSLMLRLYVDI | 241 | O94956 | |
| ATYMQFLKEGLRRGL | 571 | Q9NZV5 | |
| GVVLMLLDRYGDRLT | 541 | O43280 | |
| RLSAYVSYGGLLMRL | 111 | P52434 | |
| FGRLLDFMYEGRLDL | 76 | B2RXF5 | |
| FEGLLQLIYSGRLRL | 96 | Q96C00 | |
| IGLMDRLKGFRVYLT | 276 | A0A3B3IT33 | |
| LLRHILSQEGMRGLY | 421 | Q9BV35 | |
| MYLDEYRDRLFLGGL | 61 | Q9NS98 | |
| RGGERLLFLFSRMLL | 331 | Q9H7P9 | |
| MGRFRGGLRCIKYLL | 1 | O60636 | |
| TKMRIYLGQLQRGLF | 306 | Q9H7L9 | |
| GLCLLSLLFIGLMYR | 221 | P19438 | |
| FRGRYLLLLMGLFSI | 441 | Q13488 | |
| NYGLMRLGFLRLQAL | 786 | Q13402 | |
| FQYGITDLRGMLKRL | 231 | Q14324 |